The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
NCT01686048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2015-10-07
Summary
Ambrosia is known for its allergenicity in the USA causing hay fever and asthma. Israel has always been considered "clean" of Ambrosia but over the past years growth of Ambrosia plants has been detected in several locations in Israel.
In the proposed study, patients referred for routine allergic evaluation will also be skin tested with Ambrosia allergens, in addition to their regular prick skin tests with all other airborne allergens.
Conditions
- Allergic Rhinitis
- Asthma
- Allergic Conjunctivitis
- Atopic Dermatitis
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- Israel
Study Locations
More Related Trials
-
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
NCT03758456 ·Status: COMPLETED ·Phase: PHASE1
-
Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis
NCT05346718 ·Status: COMPLETED ·Phase: NA
-
Inhibitory Receptors in Eosinophils of Atopic Subjects
NCT01489293 ·Status: COMPLETED
-
Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
NCT02423707 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
NCT00309036 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Mechanisms of Allergy Immunotherapy
NCT01914029 ·Status: UNKNOWN
-
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 ·Status: COMPLETED
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
NCT00258635 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study in Adults Sensitized to Short Ragweed
NCT00670384 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety of ALK Ragweed Tablet
NCT00330083 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
NCT00671268 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections
NCT03038971 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration
NCT00777374 ·Status: COMPLETED ·Phase: PHASE2
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
Tolerability of ALK Tree Tablet
NCT00535639 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber
NCT04583202 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen
NCT02690935 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
NCT01385371 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation
NCT00623701 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
NCT06104293 ·Status: COMPLETED ·Phase: NA
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Tolerability of ALK Grass Tablet in Children
NCT00310453 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
NCT04891237 ·Status: RECRUITING ·Phase: PHASE3